Want to Lower Your Risk of Dementia? It Doesn't Involve a Blood Test
The guideline says blood-based biomarkers can support diagnosis in specialized care when Alzheimer’s disease is suspected, but confirmatory testing may still be needed.
5 Articles
5 Articles
Alzheimer’s blood tests are advancing diagnosis. What can they really tell us?
Blood tests such as p-tau217 and p-tau181 can help identify changes linked to Alzheimer’s disease. Neurologists explain what these tests can detect, how they aid diagnosis and what the results can and cannot tell patients
Want to lower your risk of dementia? It doesn't involve a blood test
New blood tests are helping doctors diagnose whether Alzheimer’s or something else is causing a patient’s memory problems. Those tests aren’t yet ready for the worried well, although studies are exploring if one day they might help predict who's likely…
Diagnostic and treatment approaches for Alzheimer's disease have undergone significant changes in recent years. 🚆
In the medical world, blood biomarkers developed for early diagnosis, particularly those measuring the p-tau217 protein, have ushered in a groundbreaking era in the detection of Alzheimer's pathology. Prof. Dr. Özlem Güngör Tunçer from the Neurology Department of Memorial Şişli Hospital stated that these tests are not a general screening tool and should not be applied to every person experiencing forgetfulness, providing vital information about …
While the use of blood biomarkers in Alzheimer's diagnosis is becoming increasingly common, tests measuring p-tau217 in particular are helping to determine the biology of the disease. Experts point out that these tests should not be applied to everyone who complains of forgetfulness.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
